Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Stericycle Inc    SRCL

Delayed Quote. Delayed  - 06/29 09:59:59 pm
101.98 USD   +2.03%
05/17 SAFETY FIRST : Regulators Increase Fines as Injuries Rise
05/12 STERICYCLE : Declares Dividend On Mandatory Convertible Preferred St..
05/11 Stericycle Declares Dividend On Mandatory Convertible Preferred S..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales2 1432 5562 9863 6483 8964 150
Operating income (EBITDA)6457207899651 0721 161
Operating profit (EBIT)556615662775873939
Pre-Tax Profit (EBT)478-----
Net income311326255380462520
P/E ratio32,634,640,725,020,318,6
EPS ( $ )3,563,792,964,095,015,48
Dividend per Share ( $ )------
Yield------
Reference price ( $ )116.17131.08120.6101.98101.98101.98
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt1 3691 6373 1581 1622 5822 278
Finance------
Operating income (EBITDA)6457207899651 0721 161
Leverage
(Debt/EBITDA)
2,12x2,27x4,00x1,20x2,41x1,96x
Capital Expenditure73,186,5115135137133
Book Value Per Share (BVPS)20,6 $22,4 $32,1 $33,1 $37,5 $42,7 $
Cash Flow per Share4,62 $5,20 $4,53 $5,68 $6,26 $6,94 $
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 8 659 M$ -
Entreprise Value (EV) 9 821 M$ 11 242 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 25,0x 20,3x
Capitalization / Revenue 2,37x 2,22x
EV / Revenue 2,69x 2,89x
EV / EBITDA 10,2x 10,5x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 3,08x 2,72x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 21,3% 22,4%
operating Leverage (Delta EBIT / Delta Sales) 0,77x 1,86x
Net Margin (Net Profit / Revenue) 10,4% 11,9%
ROA (Net Profit / Asset) 26,8% 8,31%
ROE (Net Profit / Equities) 14,2% 13,8%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   3,70% 3,51%
Cash Flow / Sales 13,2% 13,6%
Capital Intensity (Assets / Sales) 0,39x 1,43x
Financial Leverage (Net Debt / EBITDA) 1,20x 2,41x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend